S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
CGC   18.50 (-3.90%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
T   39.16 (-0.03%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
BAC   32.79 (-0.91%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
CGC   18.50 (-3.90%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
T   39.16 (-0.03%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
BAC   32.79 (-0.91%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
CGC   18.50 (-3.90%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
T   39.16 (-0.03%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
BAC   32.79 (-0.91%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
CGC   18.50 (-3.90%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
T   39.16 (-0.03%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
BAC   32.79 (-0.91%)
DIS   148.72 (+7.32%)
Log in

West Pharmaceutical Services Stock Price, Forecast & Analysis (NYSE:WST)

$148.21
+0.65 (+0.44 %)
(As of 11/13/2019 04:00 PM ET)
Today's Range
$146.66
Now: $148.21
$148.55
50-Day Range
$137.28
MA: $142.69
$147.93
52-Week Range
$91.75
Now: $148.21
$152.10
Volume363,695 shs
Average Volume367,450 shs
Market Capitalization$10.97 billion
P/E Ratio52.74
Dividend Yield0.43%
Beta1.25
West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. Read More…

Industry, Sector and Symbol

Industry Fabricated rubber products, not elsewhere classified
Sub-IndustryHealth Care Supplies
SectorMedical
CUSIP95530610
Phone610-594-2900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.72 billion
Cash Flow$4.28 per share
Book Value$18.85 per share

Profitability

Net Income$206.90 million

Miscellaneous

Employees7,700
Market Cap$10.97 billion
Next Earnings Date2/13/2020 (Estimated)
OptionableOptionable

Receive WST News and Ratings via Email

Sign-up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter.


West Pharmaceutical Services (NYSE:WST) Frequently Asked Questions

What is West Pharmaceutical Services' stock symbol?

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services announced a quarterly dividend on Thursday, July 25th. Stockholders of record on Wednesday, October 23rd will be paid a dividend of $0.15 per share on Wednesday, November 6th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.40%. The ex-dividend date is Tuesday, October 22nd. View West Pharmaceutical Services' Dividend History.

How will West Pharmaceutical Services' stock buyback program work?

West Pharmaceutical Services declared that its Board of Directors has authorized a stock repurchase program on Thursday, February 15th 2018, which permits the company to repurchase 800,000 outstanding shares, according to EventVestor. This repurchase authorization permits the company to purchase shares of its stock through open market purchases. Shares repurchase programs are often a sign that the company's leadership believes its stock is undervalued.

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services Inc. (NYSE:WST) released its quarterly earnings results on Thursday, October, 24th. The medical instruments supplier reported $0.79 EPS for the quarter, topping the consensus estimate of $0.71 by $0.08. The medical instruments supplier earned $456.10 million during the quarter, compared to analyst estimates of $450.03 million. West Pharmaceutical Services had a return on equity of 16.66% and a net margin of 12.82%. The company's revenue for the quarter was up 5.6% compared to the same quarter last year. During the same period last year, the firm earned $0.76 earnings per share. View West Pharmaceutical Services' Earnings History.

When is West Pharmaceutical Services' next earnings date?

West Pharmaceutical Services is scheduled to release their next quarterly earnings announcement on Thursday, February 13th 2020. View Earnings Estimates for West Pharmaceutical Services.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services issued an update on its FY19 earnings guidance on Thursday, October, 24th. The company provided EPS guidance of $3.10-3.15 for the period, compared to the Thomson Reuters consensus estimate of $3.06. The company issued revenue guidance of $1.815-1.825, compared to the consensus revenue estimate of $1.81 billion.

What price target have analysts set for WST?

3 analysts have issued twelve-month price objectives for West Pharmaceutical Services' stock. Their forecasts range from $112.16 to $122.00. On average, they expect West Pharmaceutical Services' share price to reach $117.08 in the next twelve months. This suggests that the stock has a possible downside of 21.0%. View Analyst Price Targets for West Pharmaceutical Services.

What is the consensus analysts' recommendation for West Pharmaceutical Services?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for West Pharmaceutical Services.

Has West Pharmaceutical Services been receiving favorable news coverage?

News coverage about WST stock has been trending very negative this week, according to InfoTrie. The research group scores the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. West Pharmaceutical Services earned a news sentiment score of -3.2 on InfoTrie's scale. They also assigned news articles about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for West Pharmaceutical Services.

Who are some of West Pharmaceutical Services' key competitors?

What other stocks do shareholders of West Pharmaceutical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include Johnson & Johnson (JNJ), Lowe's Companies (LOW), Mcdonald's (MCD), Nike (NKE), Stanley Black & Decker (SWK), PepsiCo (PEP), Medtronic (MDT), AFLAC (AFL), NVIDIA (NVDA) and CVS Health (CVS).

Who are West Pharmaceutical Services' key executives?

West Pharmaceutical Services' management team includes the folowing people:
  • Mr. Eric M. Green, CEO, Pres & Director (Age 49)
  • Mr. David A. Montecalvo, Sr. VP and Chief Operations & Supply Chain Officer (Age 54)
  • Mr. George Lloyd Miller, Sr. VP, Gen. Counsel & Corp. Sec. (Age 64)
  • Ms. Karen A. Flynn, Chief Commercial Officer & Sr. VP (Age 56)
  • Mr. William J. Federici, Advisor (Age 59)

Who are West Pharmaceutical Services' major shareholders?

West Pharmaceutical Services' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include WCM Investment Management LLC (1.84%), Massachusetts Financial Services Co. MA (1.27%), Fisher Asset Management LLC (1.21%), Riverbridge Partners LLC (0.80%), USS Investment Management Ltd (0.72%) and GW&K Investment Management LLC (0.46%). Company insiders that own West Pharmaceutical Services stock include Daniel Malone, Karen Flynn, Patrick J Zenner and William J Federici. View Institutional Ownership Trends for West Pharmaceutical Services.

Which institutional investors are selling West Pharmaceutical Services stock?

WST stock was sold by a variety of institutional investors in the last quarter, including USS Investment Management Ltd, Eagle Asset Management Inc., AMI Asset Management Corp, Vaughan Nelson Investment Management L.P., Public Employees Retirement Association of Colorado, Massachusetts Financial Services Co. MA, Fisher Asset Management LLC and Oppenheimer & Co. Inc.. View Insider Buying and Selling for West Pharmaceutical Services.

Which institutional investors are buying West Pharmaceutical Services stock?

WST stock was bought by a variety of institutional investors in the last quarter, including First Trust Advisors LP, WCM Investment Management LLC, State of Tennessee Treasury Department, State of New Jersey Common Pension Fund D, Chicago Equity Partners LLC, California Public Employees Retirement System, Kistler Tiffany Companies LLC and Russell Investments Group Ltd.. View Insider Buying and Selling for West Pharmaceutical Services.

How do I buy shares of West Pharmaceutical Services?

Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is West Pharmaceutical Services' stock price today?

One share of WST stock can currently be purchased for approximately $148.21.

How big of a company is West Pharmaceutical Services?

West Pharmaceutical Services has a market capitalization of $10.97 billion and generates $1.72 billion in revenue each year. The medical instruments supplier earns $206.90 million in net income (profit) each year or $2.81 on an earnings per share basis. West Pharmaceutical Services employs 7,700 workers across the globe.View Additional Information About West Pharmaceutical Services.

What is West Pharmaceutical Services' official website?

The official website for West Pharmaceutical Services is http://www.westpharma.com/.

How can I contact West Pharmaceutical Services?

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at 610-594-2900 or via email at [email protected]


MarketBeat Community Rating for West Pharmaceutical Services (NYSE WST)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  214 (Vote Outperform)
Underperform Votes:  337 (Vote Underperform)
Total Votes:  551
MarketBeat's community ratings are surveys of what our community members think about West Pharmaceutical Services and other stocks. Vote "Outperform" if you believe WST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WST will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel